Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Melanoma · In-Transit Metastasis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Netherlands Cancer Institute, Amsterdam, Netherlands
Contact: Study coordinator (Winan van Houdt, MD, PhD)Contact: Principal Investigator (Winan van Houdt, MD, PhD)Erasmus MC Cancer Institute, Groningen, Netherlands
Contact: Study coordinator (Lukas Been)Contact: Principal Investigator (Lukas Been, Md, PhD)Erasmus MC Cancer Institute, Rotterdam, Netherlands
Contact: Study coordinator (Dirk Grünhagen)Contact: Principal Investigator (Dirk Grünhagen, MD, PhD)Sahlgrenska University Hospital, Gothenburg, Sweden
Contact: Principal Investigator (Roger Olofsson Bagge, Dr)